Healthcare
Serina Therapeutics – SUCCESS PAGE – June 26, 2025
Serina Therapeutics (NYSE: SER) is pioneering drug optimization technologies to redefine the standard of care in advanced Parkinson’s and other diseases
Serina Therapeutics (NYSE: SER) is pioneering drug optimization technologies to redefine the standard of care in advanced Parkinson’s and other diseases
Nowigence AI offers a comprehensive portfolio of AI infrastructure, software, and services so companies can quickly adopt the technology
Seekr has developed SeekrFlow™, an end-to-end, enterprise scale AI foundry for business and governments built around an AI-Ready data engine.
Glazd is the first rental insurance agency designed to sell at scale with their one-to-many approach that ensures every renter has a policy
Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
Glazd is the first rental insurance agency designed to sell at scale with their one-to-many approach that ensures every renter has a policy